Francois-Xavier Frapaise

Francois-Xavier Frapaise currently works at Abbotts Ltd., as Vice President-Research & Development.
Dr. Frapaise also formerly worked at Asphelia Pharmaceuticals, Inc., as President & Chief Executive Officer, Bayer Pharma France SA, as Medical Director, Bayer Corp., as Vice President-Research & Development, Optimer Pharmaceuticals LLC, as Chief Scientific Officer & Senior Vice President from 2009 to 2011, TAP Pharmaceutical Products, Inc., as Vice President-Research & Development from 2001 to 2006, Ocera Therapeutics, Inc., as Chief Medical Officer from 2006 to 2008, Sanofi, Inc., as Vice President-Research & Development, Sanofi-Synthelabo, Inc., as Vice President-Research & Development, and Abbott International LLC, as Vice President-Scientific Affairs.
Dr. Frapaise received his doctorate degree from Université de Paris 5 René Descartes.